nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosaprepitant—TACR1—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.0331	0.091	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.0297	0.0817	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.0228	0.0628	CbGpPWpGaD
Fosaprepitant—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0205	0.0321	CcSEcCtD
Fosaprepitant—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0199	0.0312	CcSEcCtD
Fosaprepitant—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0175	0.0275	CcSEcCtD
Fosaprepitant—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0172	0.027	CcSEcCtD
Fosaprepitant—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.0262	CcSEcCtD
Fosaprepitant—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.0248	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.0142	0.0391	CbGpPWpGaD
Fosaprepitant—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.0223	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.014	0.0384	CbGpPWpGaD
Fosaprepitant—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0213	CcSEcCtD
Fosaprepitant—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0211	CcSEcCtD
Fosaprepitant—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0129	0.0203	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.0127	0.035	CbGpPWpGaD
Fosaprepitant—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0199	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0119	0.0327	CbGpPWpGaD
Fosaprepitant—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0182	CcSEcCtD
Fosaprepitant—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0176	CcSEcCtD
Fosaprepitant—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0173	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0109	0.0299	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.0107	0.0295	CbGpPWpGaD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0106	0.0293	CbGpPWpGaD
Fosaprepitant—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0165	CcSEcCtD
Fosaprepitant—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0161	CcSEcCtD
Fosaprepitant—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0159	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.0101	0.0278	CbGpPWpGaD
Fosaprepitant—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00992	0.0156	CcSEcCtD
Fosaprepitant—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00977	0.0154	CcSEcCtD
Fosaprepitant—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00977	0.0154	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00973	0.0268	CbGpPWpGaD
Fosaprepitant—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00953	0.015	CcSEcCtD
Fosaprepitant—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0095	0.0149	CcSEcCtD
Fosaprepitant—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0095	0.0149	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00937	0.0258	CbGpPWpGaD
Fosaprepitant—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00932	0.0146	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00922	0.0254	CbGpPWpGaD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00911	0.025	CbGpPWpGaD
Fosaprepitant—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00873	0.0137	CcSEcCtD
Fosaprepitant—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00867	0.0136	CcSEcCtD
Fosaprepitant—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00862	0.0135	CcSEcCtD
Fosaprepitant—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0086	0.0135	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00825	0.0227	CbGpPWpGaD
Fosaprepitant—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00818	0.0129	CcSEcCtD
Fosaprepitant—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.0128	CcSEcCtD
Fosaprepitant—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00796	0.0125	CcSEcCtD
Fosaprepitant—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.0124	CcSEcCtD
Fosaprepitant—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.0121	CcSEcCtD
Fosaprepitant—TACR1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00765	0.0211	CbGpPWpGaD
Fosaprepitant—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00764	0.012	CcSEcCtD
Fosaprepitant—TACR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00756	0.0208	CbGpPWpGaD
Fosaprepitant—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00753	0.0118	CcSEcCtD
Fosaprepitant—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00748	0.0118	CcSEcCtD
Fosaprepitant—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00734	0.0115	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0072	0.0198	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00713	0.0196	CbGpPWpGaD
Fosaprepitant—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00709	0.0111	CcSEcCtD
Fosaprepitant—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.0111	CcSEcCtD
Fosaprepitant—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.011	CcSEcCtD
Fosaprepitant—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00689	0.0108	CcSEcCtD
Fosaprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00685	0.0188	CbGpPWpGaD
Fosaprepitant—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00667	0.0105	CcSEcCtD
Fosaprepitant—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00659	0.0104	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.00652	0.0179	CbGpPWpGaD
Fosaprepitant—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.0102	CcSEcCtD
Fosaprepitant—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.0102	CcSEcCtD
Fosaprepitant—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00646	0.0101	CcSEcCtD
Fosaprepitant—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00643	0.0101	CcSEcCtD
Fosaprepitant—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00636	0.00999	CcSEcCtD
Fosaprepitant—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.00979	CcSEcCtD
Fosaprepitant—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.00979	CcSEcCtD
Fosaprepitant—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00973	CcSEcCtD
Fosaprepitant—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00611	0.00961	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00611	0.0168	CbGpPWpGaD
Fosaprepitant—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00606	0.00951	CcSEcCtD
Fosaprepitant—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.00947	CcSEcCtD
Fosaprepitant—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00564	0.00886	CcSEcCtD
Fosaprepitant—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00873	CcSEcCtD
Fosaprepitant—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.00871	CcSEcCtD
Fosaprepitant—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.00862	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00549	0.0151	CbGpPWpGaD
Fosaprepitant—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00542	0.00851	CcSEcCtD
Fosaprepitant—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.00846	CcSEcCtD
Fosaprepitant—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00537	0.00844	CcSEcCtD
Fosaprepitant—TACR1—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.00537	0.0148	CbGpPWpGaD
Fosaprepitant—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00533	0.00838	CcSEcCtD
Fosaprepitant—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00533	0.00838	CcSEcCtD
Fosaprepitant—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00807	CcSEcCtD
Fosaprepitant—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0051	0.00801	CcSEcCtD
Fosaprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00507	0.0139	CbGpPWpGaD
Fosaprepitant—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.00778	CcSEcCtD
Fosaprepitant—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.00774	CcSEcCtD
Fosaprepitant—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.00774	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00465	0.0128	CbGpPWpGaD
Fosaprepitant—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00459	0.00722	CcSEcCtD
Fosaprepitant—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00703	CcSEcCtD
Fosaprepitant—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00441	0.00693	CcSEcCtD
Fosaprepitant—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.0067	CcSEcCtD
Fosaprepitant—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00412	0.00648	CcSEcCtD
Fosaprepitant—TACR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00406	0.0112	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00403	0.0111	CbGpPWpGaD
Fosaprepitant—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00396	0.00623	CcSEcCtD
Fosaprepitant—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00618	CcSEcCtD
Fosaprepitant—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.00617	CcSEcCtD
Fosaprepitant—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00614	CcSEcCtD
Fosaprepitant—TACR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00386	0.0106	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00381	0.0105	CbGpPWpGaD
Fosaprepitant—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.00582	CcSEcCtD
Fosaprepitant—TACR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00368	0.0101	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00366	0.0101	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0035	0.00963	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00339	0.00932	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0031	0.00853	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00308	0.00847	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00296	0.00814	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00282	0.00774	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00263	0.00723	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00239	0.00657	CbGpPWpGaD
Fosaprepitant—TACR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00218	0.006	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00218	0.00598	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00216	0.00595	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00198	0.00545	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00182	0.005	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00166	0.00458	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00141	0.00388	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00137	0.00376	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.0013	0.00356	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00117	0.00322	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00108	0.00297	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.0009	0.00248	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000689	0.0019	CbGpPWpGaD
Fosaprepitant—TACR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000568	0.00156	CbGpPWpGaD
